1232 related articles for article (PubMed ID: 27434205)
1. Cellular immunotherapy for malignant gliomas.
Lin Y; Okada H
Expert Opin Biol Ther; 2016 Oct; 16(10):1265-75. PubMed ID: 27434205
[TBL] [Abstract][Full Text] [Related]
2. Cell-Based Immunotherapy of Gliomas.
Everson RG; Antonios JP; Liau LM
Prog Neurol Surg; 2018; 32():90-100. PubMed ID: 29990977
[TBL] [Abstract][Full Text] [Related]
3. The Potential of Cellular- and Viral-Based Immunotherapies for Malignant Glioma-Dendritic Cell Vaccines, Adoptive Cell Transfer, and Oncolytic Viruses.
Maxwell R; Luksik AS; Garzon-Muvdi T; Lim M
Curr Neurol Neurosci Rep; 2017 Jun; 17(6):50. PubMed ID: 28488122
[TBL] [Abstract][Full Text] [Related]
4. [Cellular immunotherapy for malignant glioma].
Okamoto Y; Yamashita J
Nihon Rinsho; 2005 Sep; 63 Suppl 9():557-62. PubMed ID: 16201581
[No Abstract] [Full Text] [Related]
5. Genetically Engineered T-Cells for Malignant Glioma: Overcoming the Barriers to Effective Immunotherapy.
Chuntova P; Downey KM; Hegde B; Almeida ND; Okada H
Front Immunol; 2018; 9():3062. PubMed ID: 30740109
[TBL] [Abstract][Full Text] [Related]
6. Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy.
Figueroa JA; Reidy A; Mirandola L; Trotter K; Suvorava N; Figueroa A; Konala V; Aulakh A; Littlefield L; Grizzi F; Rahman RL; Jenkins MR; Musgrove B; Radhi S; D'Cunha N; D'Cunha LN; Hermonat PL; Cobos E; Chiriva-Internati M
Int Rev Immunol; 2015 Mar; 34(2):154-87. PubMed ID: 25901860
[TBL] [Abstract][Full Text] [Related]
7. Adoptive cell transfer therapy for malignant gliomas.
Ishikawa E; Takano S; Ohno T; Tsuboi K
Adv Exp Med Biol; 2012; 746():109-20. PubMed ID: 22639163
[TBL] [Abstract][Full Text] [Related]
8. [Immunotherapy in brain tumors].
De Carli E; Delion M; Rousseau A
Ann Pathol; 2017 Feb; 37(1):117-126. PubMed ID: 28111040
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cell-based immunotherapy of malignant gliomas.
Parajuli P; Sloan AE
Cancer Invest; 2004; 22(3):405-16. PubMed ID: 15493362
[TBL] [Abstract][Full Text] [Related]
10. Antigen-receptor gene-modified T cells for treatment of glioma.
Ikeda H; Shiku H
Adv Exp Med Biol; 2012; 746():202-15. PubMed ID: 22639170
[TBL] [Abstract][Full Text] [Related]
11. Adoptive immunotherapy for malignant glioma.
Mitchell DA; Fecci PE; Sampson JH
Cancer J; 2003; 9(3):157-66. PubMed ID: 12952301
[TBL] [Abstract][Full Text] [Related]
12. Retargeted human avidin-CAR T cells for adoptive immunotherapy of EGFRvIII expressing gliomas and their evaluation via optical imaging.
Liu K; Liu X; Peng Z; Sun H; Zhang M; Zhang J; Liu S; Hao L; Lu G; Zheng K; Gong X; Wu D; Wang F; Shen L
Oncotarget; 2015 Sep; 6(27):23735-47. PubMed ID: 26124178
[TBL] [Abstract][Full Text] [Related]
13. Glioma antigen.
Toda M
Adv Exp Med Biol; 2012; 746():77-84. PubMed ID: 22639160
[TBL] [Abstract][Full Text] [Related]
14. Genetically Modified Cellular Therapies for Malignant Gliomas.
Kilian M; Bunse T; Wick W; Platten M; Bunse L
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884607
[TBL] [Abstract][Full Text] [Related]
15. Clinically feasible approaches to potentiating cancer cell-based immunotherapies.
Seledtsov VI; Goncharov AG; Seledtsova GV
Hum Vaccin Immunother; 2015; 11(4):851-69. PubMed ID: 25933181
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of malignant gliomas using autologous and allogeneic tissue cells.
Hofman FM; Stathopoulos A; Kruse CA; Chen TC; Schijns VE
Anticancer Agents Med Chem; 2010 Jul; 10(6):462-70. PubMed ID: 20879986
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic chimeric antigen receptor-modified cells for adoptive cell therapy of cancer.
Marcus A; Eshhar Z
Expert Opin Biol Ther; 2014 Jul; 14(7):947-54. PubMed ID: 24661086
[TBL] [Abstract][Full Text] [Related]
18. Cellular immunity and immunotherapy of brain tumors.
Prins RM; Liau LM
Front Biosci; 2004 Sep; 9():3124-36. PubMed ID: 15353342
[TBL] [Abstract][Full Text] [Related]
19. Principles of immunotherapy.
Liebelt BD; Finocchiaro G; Heimberger AB
Handb Clin Neurol; 2016; 134():163-81. PubMed ID: 26948354
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity against established intracerebral gliomas exhibited by cytotoxic T lymphocytes, but not by lymphokine-activated killer cells.
Holladay FP; Heitz T; Wood GW
J Neurosurg; 1992 Nov; 77(5):757-62. PubMed ID: 1403119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
